Patients News | pharmaphorum

News

NICE backs osteoporosis drug, but diagnosis is an obstacle

Around 14,000 women in England may soon be able to access a new treatment for osteoporosis after NICE backed routine NHS use of Theramex's Eladynos.

News

Novartis, Viatris latest targets of Henrietta Lacks lawsuits

Novartis and Viatris have become the latest pharma companies to be named in lawsuits claiming that they profited from the unlawful use of HeLa cells derived from cells taken from a cancer p

News

Anne Wojcicki, CEO and co-founder of 23andMe

23andMe board rebuffs CEO plan to take the firm private

A proposal by 23andMe founder and chief executive Anne Wojcicki to take the genetic testing company private has been rejected by a special committee of the board of directors.

News

Sonde Health launches voice-based cognitive fitness tracker

Sonde Health has made a name for itself by developing software that can detect illness from the sound of a patient's voice.

News

Valneva, LimmaTech ally on quest for first Shigella vaccine

Valneva has bolstered its vaccines pipeline with a shot designed to protect against shigellosis – a major global health threat – licensed from LimmaTech Biologics.

News

Patients resist Novo Nordisk plan to stop making Levemir

A patient advocacy group has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir, arguing that it could leave some diabetics with

NICE backs osteoporosis drug, but diagnosis is an obstacle

Novartis, Viatris latest targets of Henrietta Lacks lawsuits

23andMe board rebuffs CEO plan to take the firm private

Sonde Health launches voice-based cognitive fitness tracker

Valneva, LimmaTech ally on quest for first Shigella vaccine

Patients resist Novo Nordisk plan to stop making Levemir

White House signs pricing deals with nine more pharmas

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks